4.8 Article

Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 127, 期 6, 页码 2378-2391

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI88941

关键词

-

资金

  1. NCI [P01-CA098101]
  2. NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases [P30-DK050306]
  3. American Cancer Society
  4. Fonds de recherche en sante du Quebec [P-Giroux-27692, P-Giroux-31601]
  5. NIH/NCI [F32-CA206264, F30-CA175133]
  6. NIH [T32-DK007066-42, K01-DK103953]
  7. NIH/NIDDK [K01-DK100485]

向作者/读者索取更多资源

The esophageal lumen is lined by a stratified squamous epithelium comprised of proliferative basal cells that differentiate while migrating toward the luminal surface and eventually desquamate. Rapid epithelial renewal occurs, but the specific cell of origin that supports this high proliferative demand remains unknown. Herein, we have described a long-lived progenitor cell population in the mouse esophageal epithelium that is characterized by expression of keratin 15 (Krt15). Genetic in vivo lineage tracing revealed that the Krt15 promoter marks a long-lived basal cell population able to self-renew, proliferate, and generate differentiated cells, consistent with a progenitor/stem cell population. Transcriptional profiling demonstrated that Krt15(+) basal cells are molecularly distinct from Krt15-basal cells. Depletion of Krt15-derived cells resulted in decreased proliferation, thereby leading to atrophy of the esophageal epithelium. Further, Krt15(+) cells were radioresistant and contributed to esophageal epithelial regeneration following radiation-induced injury. These results establish the presence of a long-lived and indispensable Krt15(+) progenitor cell population that provides additional perspective on esophageal epithelial biology and the widely prevalent diseases that afflict this epithelium.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Mist1+gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice

Henrik Nienhuser, Woosook Kim, Ermanno Malagola, Tuo Ruan, Giovanni Valenti, Moritz Middelhoff, Adam Bass, Channing J. Der, Yoku Hayakawa, Timothy C. Wang

Summary: The study revealed that gastric Mist1+ isthmus cells are activated in response to injury and inflammation, playing a crucial role in the regeneration of gastric glands through the Wnt5a pathway.
Article Biochemistry & Molecular Biology

Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer

Qiaosi Tang, Ashley Lento, Kensuke Suzuki, Gizem Efe, Tatiana Karakasheva, Apple Long, Veronique Giroux, Mirazul Islam, E. Paul Wileyto, Andres J. Klein-Szanto, Hiroshi Nakagawa, Adam Bass, Anil K. Rustgi

Summary: The study reveals that TP53 mutation is the most common in ESCC, while Rab11-FIP1 gene is significantly downregulated in mutant p53 tumor cells. Genetic knockdown of Rab11-FIP1 results in increased organoid size and promotes tumor cell invasion through mutant p53.

EMBO REPORTS (2021)

Article Oncology

PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability

Jason R. Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Basil Bakir, Varun Sahu, Jinyang Li, Jun Zhao, Benoit Marchand, Maximilian D. Wengyn, Antony Hsieh, Il-Kyu Kim, Amy Zhang, Karine Sellin, Vivian Lee, Shigetsugu Takano, Yoji Miyahara, Masayuki Ohtsuka, Anirban Maitra, Faiyaz Notta, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi

Summary: The amplification of PTHrP in pancreatic cancer is related to tumor growth and metastasis, and its loss can significantly reduce tumor burden, eliminate metastasis, and enhance overall survival. Targeting PTHrP activity may be a novel therapeutic approach for treating pancreatic cancer.

CANCER DISCOVERY (2021)

Article Gastroenterology & Hepatology

Intestinal organoids: roadmap to the clinic

Magdalena Kasendra, Misty Troutt, Taylor Broda, W. Clark Bacon, Timothy C. Wang, Joyce C. Niland, Michael A. Helmrath

Summary: Recent advances in intestinal organoid research have shown promising therapeutic potential for treating severely injured or diseased bowels using induced pluripotent stem cell (iPSC)-derived organoids. However, careful planning, significant resources, and collaboration between experts from various disciplines are required to address the safety and efficacy challenges in transitioning from laboratory discovery to first-in-human clinical trials.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)

Article Cell Biology

Mutant p53 regulates Survivin to foster lung metastasis

Qiaosi Tang, Gizem Efe, Anna M. Chiarella, Jessica Leung, Maoting Chen, Taiji Yamazoe, Zhenyi Su, Jason R. Pitarresi, Jinyang Li, Mirazul Islam, Tatiana Karakasheva, Andres J. Klein-Szanto, Samuel Pan, Jianhua Hu, Shoji Natsugoe, Wei Gu, Ben Z. Stanger, Kwok-K Wong, J. Alan Diehl, Adam J. Bass, Hiroshi Nakagawa, Maureen E. Murphy, Anil K. Rustgi

Summary: Esophageal squamous cell carcinoma (ESCC) is a deadly cancer that often metastasizes to the lungs. The study investigated how the p53R175H mutation regulates metastasis in ESCC. Depletion of Trp53R172H in primary tumor cell lines led to reduced invasion and lung metastasis, with the YAP-BIRC5 axis identified as a potential mediator. Survivin, a protein encoded by BIRC5, was found to be upregulated by Trp53R172H and associated with increased metastasis in GI cancers. These findings provide new insights into mutant p53-mediated metastasis.

GENES & DEVELOPMENT (2021)

Editorial Material Cell & Tissue Engineering

Pancreatic plasticity: Unlocking exocrine lineage specification

Jason R. Pitarresi, Anil K. Rustgi

Summary: In this issue, two studies developed human stem-cell-derived organoid culture systems to mimic pancreatic acinar and ductal lineages, offering opportunities to study cellular plasticity and transformation in pancreatic cancer initiation and progression.

CELL STEM CELL (2021)

Article Biochemistry & Molecular Biology

Calcium signaling induces a partial EMT

Robert J. Norgard, Jason R. Pitarresi, Ravikanth Maddipati, Nicole M. Aiello-Couzo, David Balli, Jinyang Li, Taiji Yamazoe, Maximilian D. Wengyn, Ian D. Millstein, Ian W. Folkert, Derick N. Rosario-Berrios, Il-Kyu Kim, Jared B. Bassett, Riley Payne, Corbett T. Berry, Xiaodong Feng, Kathryn Sun, Michele Cioffi, Priyanka Chakraborty, Mohit Kumar Jolly, J. Silvio Gutkind, David Lyden, Bruce D. Freedman, J. Kevin Foskett, Anil K. Rustgi, Ben Z. Stanger

Summary: Epithelial-mesenchymal transition (EMT) is a form of cellular plasticity that gives tumor cells invasiveness and alters their sensitivity to drugs, posing a challenge to cancer therapy. Carcinoma cells in a partial EMT state have higher metastatic capacity than those in extreme states. Prolonged calcium signaling induces a partial EMT characterized by the internalization of membrane-associated E-cadherin and increased migration and invasion abilities.

EMBO REPORTS (2021)

Article Oncology

MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma

Ravikanth Maddipati, Robert J. Norgard, Timour Baslan, Komal S. Rathi, Amy Zhang, Asal Saeid, Taku Higashihara, Feng Wu, Angad Kumar, Valli Annamalai, Saurav Bhattacharya, Pichai Raman, Christian A. Adkisson, Jason R. Pitarresi, Maximilian D. Wengyn, Taiji Yamazoe, Jinyang Li, David Balli, Michael J. LaRiviere, Tuong-Vi C. Ngo, Ian W. Folkert, Ian D. Millstein, Jonathan Bermeo, Erica L. Carpenter, John C. McAuliffe, Maja H. Oktay, Rolf A. Brekken, Scott W. Lowe, Christine A. Iacobuzio-Donahue, Faiyaz Notta, Ben Z. Stanger

Summary: This study investigated the biological and functional differences driving metastasis in patients with PDAC using a mouse model. The findings revealed an association between the extent of metastasis and gene amplification or transcriptional upregulation of the MYC gene and its downstream targets. Functional experiments demonstrated that MYC promotes metastasis by recruiting tumor-associated macrophages. Further analysis showed that metastatic progression in human PDAC is associated with activation of MYC signaling pathways and MYC amplifications in metastatic patients specifically.

CANCER DISCOVERY (2022)

Editorial Material Engineering, Biomedical

Single-cell analysis of ductal differentiation

Jason R. Pitarresi, Anil K. Rustgi

Summary: The use of a microwell chip can facilitate the differentiation of aggregates of human induced pluripotent stem cells into pancreatic-duct-like organoids and characterize the differentiation process at the single-cell level.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Multidisciplinary Sciences

Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer

Tatiana A. Karakasheva, Joel T. Gabre, Uma M. Sachdeva, Ricardo Cruz-Acuna, Eric W. Lin, Maureen DeMarshall, Gary W. Falk, Gregory G. Ginsberg, Zhaohai Yang, Michele M. Kim, Eric S. Diffenderfer, Jason R. Pitarresi, Jinyang Li, Amanda B. Muir, Kathryn E. Hamilton, Hiroshi Nakagawa, Adam J. Bass, Anil K. Rustgi

Summary: This study aimed to evaluate the use of esophageal cancer PDOs created from treatment-naive patients in predicting and modeling clinical outcomes. Results showed that PDOs could mirror clinical responses, suggesting their potential value in predicting clinical response to new therapeutic approaches. Future clinical trials should further explore the use of pre-treatment PDOs for personalized therapies in patients with esophageal adenocarcinoma.

SCIENTIFIC REPORTS (2021)

Editorial Material Biochemistry & Molecular Biology

R-spondin signaling in the stomach: isthmal Lgr4 rules

Ermanno Malagola, Yoku Hayakawa, Timothy C. Wang

Summary: Recent research has identified distinct roles for Lgr4 and Lgr5 in directing gland reconstitution following H. pylori infection, shedding new light on the complexities of Rspo signaling during gastric regeneration and raising questions about antral stem cell hierarchy.

EMBO JOURNAL (2022)

Article Biology

STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer

Julia E. Lefler, Catherine B. MarElia-Bennett, Katie A. Thies, Blake E. Hildreth, Sudarshana M. Sharma, Jason R. Pitarresi, Lu Han, Caroline Everett, Christopher Koivisto, Maria C. Cuitino, Cynthia Timmers, Elizabeth O'Quinn, Melodie Parrish, Martin J. Romeo, Amanda J. Linke, G. Aaron Hobbs, Gustavo Leone, Denis C. Guttridge, Teresa A. Zimmers, Gregory B. Lesinski, Michael C. Ostrowski

Summary: Disruption of the STAT3 signaling axis in stromal fibroblasts through genetic ablation of Stat3 slows tumor progression, increases survival, and reshapes the immune-suppressive tumor micro-environment in a PDAC mouse model. Loss of the tumor suppressor PTEN in pancreatic CAFs leads to increased STAT3 phosphorylation and promotes secretion of CXCL1.

LIFE SCIENCE ALLIANCE (2022)

Article Cell Biology

Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth

Toni T. Lemmetyinen, Emma W. Viitala, Linnea Wartiovaara, Tuomas Kaprio, Jaana Hagstrom, Caj Haglund, Pekka Katajisto, Timothy C. Wang, Eva Domenech-Moreno, Saara Ollila

Summary: Growth factors secreted by stromal fibroblasts, such as NRG1 and EREG, play a crucial role in regulating the intestinal epithelium. NRG1 promotes epithelial regeneration and protects against radiation-induced damage, while also suppressing the stem cell pool and remodeling the actin cytoskeleton. Interestingly, NRG1 does not support the growth of pre-tumorigenic intestinal organoids lacking the tumor suppressor Apc, suggesting a tumor-suppressive function.

DISEASE MODELS & MECHANISMS (2023)

Article Oncology

Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia

Jung Eun Baik, Li Li, Manish A. Shah, Daniel E. Freedberg, Zhezhen Jin, Timothy C. Wang, Yiping W. Han

Summary: Fusobacterium nucleatum (Fn) is a common gram-negative anaerobic bacterium that promotes colorectal cancer development through the secretion of FadAc. This study found that circulating levels of anti-FadAc IgA were significantly increased in patients with colorectal cancer, particularly in those with proximal tumors. Therefore, anti-FadAc IgA may serve as a serological biomarker for early detection of colorectal cancer.

CANCER RESEARCH COMMUNICATIONS (2022)

暂无数据